Clinical trial
Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment. A Proof of Concept Phase 2a Clinical Trial.
NCT05250752 is registered in ClinicalTrials.gov with Holbaek Sygehus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment. A Proof of Concept Phase 2a Clinical Trial.
- Lead sponsor
- Holbaek Sygehus
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 18, 2021
- Completion date
- December 31, 2022
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, peritoneal dialysis complication